NEC and Taiho selected for NEDO quantum immunotherapy demo program
NEC and Taiho Pharmaceutical are involved in a joint R&D project using quantum computing for next-generation cancer immunotherapy, selected for a NEDO demonstration program.
NEC and Taiho Pharmaceutical are involved in a joint R&D project using quantum computing for next-generation cancer immunotherapy, selected for a NEDO demonstration program.